San Francisco Sentry Investment Group’s ResMed RMD Stock Holding History

San Francisco Sentry Investment Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$2K	Hold	8	–	–	﹤0.01%	659
2021 Q1	$2K	Hold	8	–	–	﹤0.01%	687
2020 Q4	$2K	Hold	8	–	–	﹤0.01%	653
2020 Q3	$1K	Buy	+8	New	+$1.48K	﹤0.01%	665
2020 Q2	–	Sell	-7	Closed	-$1K	–	833
2020 Q1	$1K	Buy	+7	New	+$1.11K	﹤0.01%	801
2019 Q1	–	Sell	-30	Closed	-$3K	–	1041
2018 Q4	$3K	Sell	30 -24	-44%	-$2.57K	﹤0.01%	723
2018 Q3	$6K	Buy	+54	New	+$5.92K	﹤0.01%	653

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

San Francisco Sentry Investment Group's RMD Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its ResMed (RMD) position steady in Q2 2021 at 8 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

San Francisco Sentry Investment Group first reported a position in RMD in Q3 2018 and has held it in 7 quarters since. The position peaked at $6K in Q3 2018. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

San Francisco Sentry Investment Group held 8 shares of ResMed worth $2K as of Q2 2021.
San Francisco Sentry Investment Group left its ResMed share count unchanged in Q2 2021.
ResMed made up ﹤0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #659 holding.
San Francisco Sentry Investment Group first reported a position in ResMed in Q3 2018 and has held it in 7 quarters since.
San Francisco Sentry Investment Group's ResMed position peaked at $6K in Q3 2018.
661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.